Sichuan Kelun Pharmaceutical Co., Ltd.



Quote for Sichuan Kelun Pharmaceutical Co., Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002422
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002422 quote

Summary for Sichuan Kelun Pharmaceutical Co., Ltd.

SICHUAN KELUN PHARMACEUTICAL CO., LTD. is principally engaged in the research, development, manufacture and distribution of pharmaceutical products. The Company primarily provides high-volume injection, including glucose injection, sodium chloride injection, glucose and sodium chloride injection, ofloxacin injection, metronidazole injection and norfloxacin injection, among others, as well as non high-volume injection. Through its subsidiary, the Company also involves in the provision of tablets, capsules, powder injections, freeze-dry powder injections and Chinese medicine oral liquids, among others. The Company distributes its products within domestic markets and to overseas markets.

Profile for Sichuan Kelun Pharmaceutical Co., Ltd.

Full Name:Sichuan Kelun Pharmaceutical Co., Ltd.
Full Name in Chinese:四川科伦药业股份有限公司 Short Name in Chinese:科伦药业
Symbol/Stock Code:
002422
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Liu Gexin
Secretary of the Board:
Xiong Ying
Phone:
+86-28-82998999
Fax:
+86-28-86131248
Official Website:www.kelun.com
E-mail:kelun@kelun.com
Address:No.36,Baihua West Road, Qingyang Distr,CHENGDU SIC 610071
IPO Subscription Date:
2010-05-24
Listing Date:
2010-06-03
IPO Issued Capital:
60000000
IPO Price:
83.36 CNY
IPO fees:
229602800 CNY
Money Raised by IPO:
5001600000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
4771997200 CNY
Open(Listing day):
83.36 CNY
Close(Listing day):
89.64 CNY
Diluted P/E ratio after IPO:
48.1600
Turnover rate(listing day):
76.35%

Financials for Sichuan Kelun Pharmaceutical Co., Ltd.

UPDATE:2012-10-24 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
766.7611
966.1261
661.2292
427.8514
Net Profit Growth(%)
11.53
46.11
54.54
38.06
Return On Equity(ROE)(%)
9.04
12.33
9.46
27.29
Debt ratio(%)
35.94
24.21
20.06
52.61
Net Operating Cash Flow/Net Profit(%)
40.10
35.50
22.58
58.59

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
1.6000
2.0100
1.5400
2.3800
Diluted Earnings Per Share
0.0000
1.9100
1.5300
2.3100
Net Asset Value Per Share (NAVPS)
17.6700
16.3300
29.1300
8.7100
Additional Paid-In Capital Per Share
9.6833
9.6952
20.3899
1.0676
Retained Earnings Per Share
6.5524
5.1897
7.1476
6.1127
Net Cash Flow From Operatings Activities Per Share
0.6400
0.7100
0.6200
1.3900
Net Cash Flow Per Share
0.0951
-4.3693
15.9348
0.6681

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
13627.2077
10465.3724
8789.9002
3333.3976
Total Liabilities(Million)
4897.8975
2534.4021
1738.2625
1753.9874
Current Liabilities(Million)
2823.0517
2170.7077
1545.1631
1658.6068
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
2137.8216
2090.7417
4207.4709
516.6068
Accounts Receivables(Million)
1747.8128
1315.3145
923.993
615.2048
Deposit Received(Million)
10.6356
1.9591
0.1095
2.5533
Other Receivables(Million)
130.0855
44.928
24.4946
27.0924
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
8479.5428
7836.9545
6990.7035
1568.0765
Debt ratio(%)
35.94
24.21
20.06
52.61
Equity Ratio(%)
62.2200
74.8800
79.2400
47.0400
Current Ratio
2.3694
2.6087
4.2906
1.3837
Quick Ratio
1.9271
2.1068
3.7663
1.0249

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
4818.9046
5140.777
4040.0727
3230.5174
Net Cash Flow From Operatings Activities(Million)
307.4629
342.9311
149.292
250.6886
Net Cash Flow From Operatings Activities Change(%)
42.80
129.70
-40.45
13.39
Net Cash Flow(Million)
45.6349
-2097.2875
3824.3408
120.2635
Cash From Selling Commodities/Prime Revenue(%)
110.69
99.86
100.34
99.52
Net Cash Flow/Net Profit(%)
5.95
-217.08
578.37
28.11
Cash Flow From Investing Activities(Million)
-2108.6757
-2610.7168
-957.827
-319.0715
Cash Flow From Financing Activities(Million)
1846.8477
170.4983
4632.8758
188.6464

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
4353.7088
5147.8488
4026.4
3245.9853
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
528.3886
692.3642
592.4438
500.8893
Administrative Costs(Million)
366.7073
392.1513
262.9979
172.1153
Financing Costs(Million)
57.4856
3.2823
7.7904
46.0642
Above Three Costs Change(%)
18.05
26.01
20.05
25.70
Operating Profit(Million)
820.3318
1060.2256
754.4085
505.556
Income From Investment(Million)
1.189
-7.2281
-
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
69.4254
57.8161
20.6884
16.3603
Total Profit(Million)
889.7572
1118.0417
775.0969
521.9162
Corporate Income Tax(Million)
122.4326
157.0497
113.4096
87.745
Net Profit(Million)
766.7611
966.1261
661.2292
427.8514
Gross Profit Ratio(%)
41.70
42.79
41.05
38.66
Operating Margin(%)
18.84
20.59
18.73
15.57
Return On Equity(ROE)(%)
9.04
12.33
9.46
27.29

Announcements for Sichuan Kelun Pharmaceutical Co., Ltd.

Date: 2012-07-17
Title: EGM RESOLUTION
The Company held its 2nd Extraordinary General Meeting of 2012 on 16 July 2012, during which the following proposal(s) was/were approved:
1. Re-election of non-independent directors including Liu Gexin, Cheng Zhipeng, Pan Hui, Liu Sichuan, Yu Mingde, Wu Min(cumulative voting system is applicable)
2. Re-election of independent directors including Zhang Qiang, Liu Hong, Zhang Tengwen(cumulative voting system is applicable)
3. Re-election of shareholder representative supervisors including Liu Weihua, Xue Weigang(cumulative voting system is applicable)
4. Determination of remuneration for directors
5. Amendments to the Company's articles of association.
Date: 2012-07-11
Title: EGM REMINDER
The Company will hold the 2nd Extraordinary General Meeting of 2012 at 09:00 on 16 July 2012.

Meeting agenda:
1. Re-election of non-independent directors including Liu Gexin, Cheng Zhipeng, Pan Hui, Liu Sichuan, Yu Mingde, Wu Min(cumulative voting system is applicable)
2. Re-election of independent directors including Zhang Qiang, Liu Hong, Zhang Tengwen(cumulative voting system is applicable)
3. Re-election of shareholder representative supervisors including Liu Weihua, Xue Weigang(cumulative voting system is applicable)
4. Determination of remuneration for directors
5. Amendments to the Company's articles of association
Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 10 July 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 13 July 2012.
Date: 2012-06-29
Title: EGM-SPOT
The Company will hold the 2nd Extraordinary General Meeting of 2012 at 09:00 on 16 July 2012.

Meeting agenda:
1. Re-election of non-independent directors including Liu Gexin, Cheng Zhipeng, Pan Hui, Liu Sichuan, Yu Mingde, Wu Min(cumulative voting system is applicable)
2. Re-election of independent directors including Zhang Qiang, Liu Hong, Zhang Tengwen(cumulative voting system is applicable)
3. Re-election of shareholder representative supervisors including Liu Weihua, Xue Weigang(cumulative voting system is applicable)
4. Determination of remuneration for directors
5. Amendments to the Company's articles of association

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 10 July 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 13 July 2012
Date: 2012-04-18
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 17 April 2012, during which the following proposal(s) was/were approved:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 annual report and its summary
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. 2012 continuing connected transactions estimate
7. Reappointment of audit firm
8. Provision of financial aids to some companies
9. Eligibility for issue of corporate bonds
10. Scheme for issue of corporate bonds
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY2.50000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none.
Date: 2012-04-11
Title: AGM REMINDER
The Company will hold the 2011 Annual General Meeting at 14:00 on 17 April 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 annual report and its summary
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. 2012 continuing connected transactions estimate
7. Reappointment of audit firm
8. Provision of financial aids to some companies
9. Eligibility for issue of corporate bonds
10. Scheme for issue of corporate bonds
1) Cash dividend/10 shares (tax included): CNY2.50000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 11 April 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.
Registration period: 13 April 2012

The Company's shareholder may choose to vote online via the trading system of Shenzhen Stock Exchange or via the website of http://wltp.cninfo.com.cn.

Part I Voting via the trading system
Voting date: 17 April 2012
Voting code:362422
Voting abbreviation:Kelun Pharmaceutical voting
Voting process:
1. To input the "buy" instruction to begin voting
2.To input the serial number of the Annual General Meeting proposals under the item of "subscription price" "1 share" for voting for, "2 shares" for voting against and "3 shares" for "abstention".

Part II Voting via the internet
Shareholders may choose the CA (certification authority) or service password for identity verification. As to the service password, shareholders may apply for a password on the website http://www.szse.cn or http://wltp.cninfo.com.cn.
Voting period: from 16 April 2012 to 17 April 2012.
Date: 2012-03-27
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 27 March 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY2.50000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):none.
Date: 2012-03-27
Title: AGM-ONLINE
The Company will hold the 2011 Annual General Meeting at 14:00 on 17 April 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 annual report and its summary
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. 2012 continuing connected transactions estimate
7. Reappointment of audit firm
8. Provision of financial aids to some companies
9. Eligibility for issue of corporate bonds
10. Scheme for issue of corporate bonds
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY2.50000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1.A-share holders registered at CSDCC Shenzhen after the close of trading on 11 April 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.
Registration period: 13 April 2012

The Company's shareholder may choose to vote online via the trading system of Shenzhen Stock Exchange or via the website of http://wltp.cninfo.com.cn.

Part I Voting via the trading system
Voting date: 17 April 2012
Voting code:362422
Voting abbreviation:Kelun Pharmaceutical voting
Voting process:
1. To input the "buy" instruction to begin voting
2.To input the serial number of the annual general meeting proposals under the item of "subscription price" "1 share" for voting for, "2 shares" for voting against and "3 shares" for "abstention".

Part II Voting via the internet
shareholders may choose the CA (certification authority) or service password for identity verification. As to the service password, shareholders may apply for a password on the website http://www.szse.cn or http://wltp.cninfo.com.cn.
Voting period: from 16 April 2012 to 17 April 2012.
Date: 2012-02-28
Title: EGM RESOLUTION
The Company held its 1st Extraordinary General Meeting of 2012 on 27 February 2012, during which the following proposal(s) was/were approved:
1. Amendments to the Company's articles of association
2. Absorption and merger of a wholly-owned subsidiary and change in the implementing party of project invested with raised funds
3. Change in the use of partial raised funds
4. Confirmation of acquisition of equity of a company
5. Amendments to the rules of procedures for general meetings
6. The Company and its subsidiaries (branches) to finance from banks
7. Absorption and merger of another wholly-owned subsidiary
8. Provision of financial aids to some controlled subsidiaries
9. A company to absorb and merge another company and change in the implementing party of projects invested with raised funds.
Date: 2012-02-22
Title: EGM REMINDER
The Company will hold the 1st Extraordinary General Meeting of 2012 at 09:00 on 27 February 2012.

Meeting agenda:
1. Amendments to the Company's articles of association
2. Absorption and merger of a wholly-owned subsidiary and change in the implementing party of project invested with raised funds
3. Change in the use of partial raised funds
4. Confirmation of acquisition of equity of a company
5. Amendments to the rules of procedures for general meetings
6. The Company and its subsidiaries (branches) to finance from banks
7. Absorption and merger of another wholly-owned subsidiary
8. Provision of financial aids to some controlled subsidiaries
9. A company to absorb and merge another company and change in the implementing party of projects invested with raised funds
Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 22 February 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 22 February 2012.
Date: 2011-06-01
Title: RESTRICTED SHARE LISTING
THE CO'S 169,490,970 RESTRICTED A-SHARES WILL BE LISTED ON THE SHENZHEN STOCK EXCHANGE AS OF 03JUN11.